Mathematical modeling of impacts of patient differences on renin-angiotensin system and applications to COVID-19 lung fibrosis outcomes
Computers in Biology and Medicine,
Journal Year:
2025,
Volume and Issue:
186, P. 109631 - 109631
Published: Jan. 2, 2025
Language: Английский
Circulating Autoantibodies Against Vasoactive Biomarkers Related to Orthostatic Intolerance in Long COVID Patients Compared to No-Long-COVID Populations: A Case-Control Study
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(2), P. 300 - 300
Published: Feb. 18, 2025
Endothelial
dysfunction
mediated
by
elevated
levels
of
autoantibodies
against
vasoactive
peptides
occurring
after
COVID-19
infection
is
proposed
as
a
possible
pathomechanism
for
orthostatic
intolerance
in
long
COVID
patients.
This
case-control
study
comprised
100
patients
from
our
prospective
POSTCOV
registry
and
three
control
groups,
each
consisting
20
individuals
(Asymptomatic
post-COVID
group;
Healthy
group
=
pan-negative
antispike
protein
SARS-CoV-2;
Vaccinated
healthy
no
history
vaccinated).
Autoantibodies
towards
muscarinic
acetylcholine
receptor
M3,
endothelin
type
A
(ETAR),
beta-2
adrenergic
(Beta-2
AR),
angiotensin
II
1
1-7
(Ang1-7)
concentrations
were
measured
enzyme-linked
immunosorbent
assay
controls.
Orthostatic
was
defined
inappropriate
sinus
tachycardia,
postural
hypotonia
other
dysautonomia
symptoms,
such
dizziness
or
blurred
vision
(n
38
patients).
Autoantibody
compared
with
routine
laboratory
parameters
quality
life
questionnaires
(EQ-5D).
The
concentration
ETAR
significantly
higher
COVID,
Asymptomatic
groups
to
the
group.
trend
plasma
Beta-2
AR
Ang1-7
patients,
not
related
presence
intolerance.
autoantibody
showed
significant
positive
correlation
EQ-5D
item
"Problems
performing
usual
activities".
Language: Английский
Mathematical Modeling of Impacts of Patient Differences on Renin-Angiotensin System and Applications to COVID-19 Lung Fibrosis Outcomes
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Nov. 7, 2022
Abstract
Patient-specific
premorbidity,
age,
and
sex
are
significant
heterogeneous
factors
that
influence
the
severe
manifestation
of
lung
diseases,
including
COVID-19
fibrosis.
The
renin-angiotensin
system
(RAS)
plays
a
prominent
role
in
regulating
effects
these
factors.
Recent
evidence
shows
patient-specific
alterations
RAS
homeostasis
concentrations
with
premorbidity
expression
level
angiotensin-converting
enzyme
2
(ACE2)
during
COVID-19.
However,
conflicting
suggests
decreases,
increases,
or
no
changes
peptides
after
SARS-CoV-2
infection.
In
addition,
detailed
mechanisms
connecting
conditions
before
infection
to
infection-induced
still
unknown.
Here,
multiscale
computational
model
was
developed
quantify
systemic
contribution
Three
submodels
were
connected—an
agent-based
for
in-host
response
tissue,
dynamics
model,
fibrosis
investigate
patient-group-specific
alteration
collagen
deposition
lung.
results
indicated
cell
death
due
inflammatory
as
major
contributor
reduction
ACE
ACE2.
contrast,
there
ACE2
viral-bound
internalization
explained
possible
previously
published
studies.
Simulated
consistent
reported
peptide
values
SARS-CoV-2-negative
SARS-CoV-2-positive
patients.
decreased
all
virtual
patient
groups
aging
both
sexes.
large
variations
magnitude
observed
between
male
female
patients
older
middle-aged
groups.
also
affected
showed
feedback
signaling
renin
could
restore
ANGI
concentration
but
failed
downstream
ANGI.
age
significantly
altered
led
slight
depending
on
sex.
This
may
find
further
applications
calibrations
tissue
models
acute
chronic
diseases
develop
personalized
treatments.
Language: Английский